vs

Side-by-side financial comparison of Krispy Kreme, Inc. (DNUT) and LifeStance Health Group, Inc. (LFST). Click either name above to swap in a different company.

Krispy Kreme, Inc. is the larger business by last-quarter revenue ($392.4M vs $382.2M, roughly 1.0× LifeStance Health Group, Inc.). LifeStance Health Group, Inc. runs the higher net margin — 3.1% vs -7.1%, a 10.1% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs -2.9%). LifeStance Health Group, Inc. produced more free cash flow last quarter ($46.6M vs $27.9M). Over the past eight quarters, LifeStance Health Group, Inc.'s revenue compounded faster (12.8% CAGR vs -5.9%).

Krispy Kreme, Inc. is an American multinational doughnut company and coffeehouse chain. Krispy Kreme was founded by Vernon Rudolph (1915–1973), who bought a yeast-raised recipe from a New Orleans chef, rented a building in 1937 in what is now historic Old Salem in Winston-Salem, North Carolina, and began selling to local grocery stores. Steady growth preceded an ambitious expansion as a public company in the period 2000 to 2016, which ultimately proved unprofitable. In 2016, the company retur...

Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.

DNUT vs LFST — Head-to-Head

Bigger by revenue
DNUT
DNUT
1.0× larger
DNUT
$392.4M
$382.2M
LFST
Growing faster (revenue YoY)
LFST
LFST
+20.3% gap
LFST
17.4%
-2.9%
DNUT
Higher net margin
LFST
LFST
10.1% more per $
LFST
3.1%
-7.1%
DNUT
More free cash flow
LFST
LFST
$18.7M more FCF
LFST
$46.6M
$27.9M
DNUT
Faster 2-yr revenue CAGR
LFST
LFST
Annualised
LFST
12.8%
-5.9%
DNUT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DNUT
DNUT
LFST
LFST
Revenue
$392.4M
$382.2M
Net Profit
$-27.8M
$11.7M
Gross Margin
Operating Margin
-1.9%
4.7%
Net Margin
-7.1%
3.1%
Revenue YoY
-2.9%
17.4%
Net Profit YoY
-23.8%
264.1%
EPS (diluted)
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DNUT
DNUT
LFST
LFST
Q4 25
$392.4M
$382.2M
Q3 25
$375.3M
$363.8M
Q2 25
$379.8M
$345.3M
Q1 25
$375.2M
$333.0M
Q4 24
$404.0M
$325.5M
Q3 24
$379.9M
$312.7M
Q2 24
$438.8M
$312.3M
Q1 24
$442.7M
$300.4M
Net Profit
DNUT
DNUT
LFST
LFST
Q4 25
$-27.8M
$11.7M
Q3 25
$-19.4M
$1.1M
Q2 25
$-435.3M
$-3.8M
Q1 25
$-33.3M
$709.0K
Q4 24
$-22.4M
$-7.1M
Q3 24
$39.6M
$-6.0M
Q2 24
$-5.5M
$-23.3M
Q1 24
$-8.5M
$-21.1M
Operating Margin
DNUT
DNUT
LFST
LFST
Q4 25
-1.9%
4.7%
Q3 25
-1.9%
2.0%
Q2 25
-114.4%
-0.9%
Q1 25
-5.4%
0.5%
Q4 24
-2.8%
0.3%
Q3 24
-4.2%
0.0%
Q2 24
1.6%
-5.1%
Q1 24
2.7%
-5.6%
Net Margin
DNUT
DNUT
LFST
LFST
Q4 25
-7.1%
3.1%
Q3 25
-5.2%
0.3%
Q2 25
-114.6%
-1.1%
Q1 25
-8.9%
0.2%
Q4 24
-5.6%
-2.2%
Q3 24
10.4%
-1.9%
Q2 24
-1.3%
-7.5%
Q1 24
-1.9%
-7.0%
EPS (diluted)
DNUT
DNUT
LFST
LFST
Q4 25
$-0.18
Q3 25
$-0.11
Q2 25
$-2.55
Q1 25
$-0.20
Q4 24
$-0.13
Q3 24
$0.23
Q2 24
$-0.03
Q1 24
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DNUT
DNUT
LFST
LFST
Cash + ST InvestmentsLiquidity on hand
$42.4M
$248.6M
Total DebtLower is stronger
$911.9M
$282.8M
Stockholders' EquityBook value
$650.1M
$1.5B
Total Assets
$2.6B
$2.2B
Debt / EquityLower = less leverage
1.40×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DNUT
DNUT
LFST
LFST
Q4 25
$42.4M
$248.6M
Q3 25
$30.7M
$203.9M
Q2 25
$21.3M
$188.9M
Q1 25
$18.7M
$134.3M
Q4 24
$29.0M
$154.6M
Q3 24
$25.4M
$102.6M
Q2 24
$28.6M
$87.0M
Q1 24
$33.1M
$49.5M
Total Debt
DNUT
DNUT
LFST
LFST
Q4 25
$911.9M
$282.8M
Q3 25
$906.2M
$284.6M
Q2 25
$889.4M
$286.4M
Q1 25
$935.0M
$288.2M
Q4 24
$844.5M
$290.0M
Q3 24
$804.6M
$287.3M
Q2 24
$895.0M
$288.0M
Q1 24
$881.8M
$288.8M
Stockholders' Equity
DNUT
DNUT
LFST
LFST
Q4 25
$650.1M
$1.5B
Q3 25
$670.3M
$1.5B
Q2 25
$693.6M
$1.5B
Q1 25
$1.1B
$1.5B
Q4 24
$1.1B
$1.4B
Q3 24
$1.2B
$1.4B
Q2 24
$1.1B
$1.4B
Q1 24
$1.2B
$1.4B
Total Assets
DNUT
DNUT
LFST
LFST
Q4 25
$2.6B
$2.2B
Q3 25
$2.6B
$2.1B
Q2 25
$2.6B
$2.1B
Q1 25
$3.1B
$2.1B
Q4 24
$3.1B
$2.1B
Q3 24
$3.1B
$2.1B
Q2 24
$3.2B
$2.1B
Q1 24
$3.2B
$2.1B
Debt / Equity
DNUT
DNUT
LFST
LFST
Q4 25
1.40×
0.19×
Q3 25
1.35×
0.19×
Q2 25
1.28×
0.19×
Q1 25
0.85×
0.20×
Q4 24
0.74×
0.20×
Q3 24
0.68×
0.20×
Q2 24
0.79×
0.20×
Q1 24
0.76×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DNUT
DNUT
LFST
LFST
Operating Cash FlowLast quarter
$45.0M
$57.6M
Free Cash FlowOCF − Capex
$27.9M
$46.6M
FCF MarginFCF / Revenue
7.1%
12.2%
Capex IntensityCapex / Revenue
4.4%
2.9%
Cash ConversionOCF / Net Profit
4.93×
TTM Free Cash FlowTrailing 4 quarters
$-64.0M
$110.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DNUT
DNUT
LFST
LFST
Q4 25
$45.0M
$57.6M
Q3 25
$42.3M
$27.3M
Q2 25
$-32.5M
$64.4M
Q1 25
$-20.8M
$-3.1M
Q4 24
$27.0M
$62.3M
Q3 24
$3.3M
$22.7M
Q2 24
$33.2M
$44.1M
Q1 24
$-17.7M
$-21.8M
Free Cash Flow
DNUT
DNUT
LFST
LFST
Q4 25
$27.9M
$46.6M
Q3 25
$15.5M
$17.0M
Q2 25
$-60.8M
$56.6M
Q1 25
$-46.7M
$-10.3M
Q4 24
$-6.9M
$56.0M
Q3 24
$-22.9M
$17.7M
Q2 24
$1.6M
$39.0M
Q1 24
$-46.8M
$-26.9M
FCF Margin
DNUT
DNUT
LFST
LFST
Q4 25
7.1%
12.2%
Q3 25
4.1%
4.7%
Q2 25
-16.0%
16.4%
Q1 25
-12.5%
-3.1%
Q4 24
-1.7%
17.2%
Q3 24
-6.0%
5.7%
Q2 24
0.4%
12.5%
Q1 24
-10.6%
-9.0%
Capex Intensity
DNUT
DNUT
LFST
LFST
Q4 25
4.4%
2.9%
Q3 25
7.1%
2.8%
Q2 25
7.4%
2.2%
Q1 25
6.9%
2.2%
Q4 24
8.4%
1.9%
Q3 24
6.9%
1.6%
Q2 24
7.2%
1.6%
Q1 24
6.6%
1.7%
Cash Conversion
DNUT
DNUT
LFST
LFST
Q4 25
4.93×
Q3 25
25.34×
Q2 25
Q1 25
-4.36×
Q4 24
Q3 24
0.08×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons